Format

Send to

Choose Destination
Clin Rehabil. 2010 Mar;24(3):222-9. doi: 10.1177/0269215509346083. Epub 2010 Feb 15.

Randomized control of extracorporeal shock wave therapy versus placebo for chronic decubitus ulceration.

Author information

1
Institute of Neuropalliative Rehabilitation, Royal Hospital for Neuro-disability, West Hill, Putney, London, UK.

Abstract

OBJECTIVE:

To assess whether extracorporeal shock wave therapy increases the rate of healing in chronic decubitus ulceration.

DESIGN:

Double-blind randomized cross-over study.

SETTING:

A large, long-stay hospital specializing in the management of people with complex neurological disabilities.

SUBJECTS:

The total population of available patients with chronic neurological conditions and chronic decubitus ulceration who met the inclusion criteria.

INTERVENTIONS:

Ulcers were randomized into receiving either the extracorporeal shock wave therapy or the placebo for a four-week period, followed by a two-week 'washout' period followed by a four-week period of the cross-over treatment/ placebo.

MAIN MEASURES:

Measurement of the area of the ulceration. For each observation the average of three measurements were taken.

RESULTS:

Nine ulcers (in eight patients) were included in the study: five on the buttocks/sacrum/trochanter and four on the feet/ankles. All those with static chronic ulcers showed improved healing starting 6-8 weeks after the start of extracorporeal shock wave therapy, whether treated first with the placebo or the therapy.

CONCLUSIONS:

Extracorporeal shock wave therapy has a potential part to play in the treatment of chronic skin ulceration.

PMID:
20156981
DOI:
10.1177/0269215509346083
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center